arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

National HealthCare Corporation

NHC Health Care Hospital/Nursing Management
$218.64
▲ +0.1% Today
as of Sep 4, 16:52 ET
Last 30 days -5.35% Jul 28 → Sep 04
$205.92 $214.20 $222.47 $230.75 $239.03 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$218.49
High
$222.54
Low
$215.93
Volume
$60,731
Avg Vol
$100,718
Mkt Cap
$3.7B
P/E (TTM)
29.91
Beta
—
52w High
$239.29
52w Low
$112.40
Div Yield
—
Shares Out
$16M

Recent Press Releases & News last 60 days · 8 items

Sep 2 · 20:18 MT Newswires
National Healthcare Insider Sold Shares Worth $1,593,000, According to a Recent SEC Filing
Aug 20 · 20:23 MT Newswires
National Healthcare Insider Sold Shares Worth $355,620, According to a Recent SEC Filing
Aug 7 · 11:00 PR Business Wire
NHC Reports Second Quarter 2026 Earnings
▸ Show all 8 press releases & news Free account →

Overview

52-week range
$112
$239
84% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+8.2%
100% positive
Latest IV / EM
31%
EM ±4.9% · $220 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.68$1.19$1.71$2.22$2.73 Actual $0.76Actual $1.06Actual $0.68Actual $1.69Actual $1.73Actual $2.73Actual $1.52Actual $1.57Actual $2.50Actual $1.91Actual $2.54 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$107M$214M$321M$428M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.54 — — — — financials
Fri May 8, 2026Mar/2026 $1.91 — — +25.7% +10.2% earnings
Tue Sep 30, 2025Sep 2025 $2.50 — — — — financials
Fri Aug 8, 2025Jun/2025 $1.57 — — — — earnings
Fri May 9, 2025Mar/2025 $1.52 — — — +6.2% earnings
Mon Sep 30, 2024Sep 2024 $2.73 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.73 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.69 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.68 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.76 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$408M$382M—$383M$375M$374M—$340M
Cost of revenue————————
Gross profit————————
Operating income$49M$32M—$30M$34M$31M—$23M
Net income$40M$36M—$39M$24M$32M—$43M
EPS (diluted)$2.54$2.27—$2.50$1.52$2.07—$2.73

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$39M$86M$93M$131M$111M$90M$76M$85M
Inventory$9M$9M$8M$8M$8M$8M$9M$8M
Total current assets$440M$466M$462M$494M$463M$455M$424M$446M
Total assets$1.54B$1.52B$1.53B$1.57B$1.56B$1.55B$1.52B$1.56B
Long-term debt$0$0$32M$66M$102M$126M$130M—
Total liabilities$409M$427M$452M$514M$537M$541M$541M$576M
Total equity$1.12B$1.10B$1.07B$1.05B$1.03B$1.01B$980M$987M

Implied volatility — last 90 days

28%50%73%95%118% Jun 07 — IV 31% · EM ±4.3%Jun 08 — IV 38% · EM ±5.0%Jun 09 — IV 36% · EM ±4.5%Jun 10 — IV 36% · EM ±4.3%Jun 11 — IV 32% · EM ±3.6%Jun 12 — IV 28% · EM ±2.9%Jun 15 — IV 45% · EM ±3.3%Jun 16 — IV 62% · EM ±3.6%Jun 17 — IV 82% · EM ±3.4%Jun 19 — IV 29% · EM ±6.3%Jun 22 — IV 35% · EM ±7.3%Jun 23 — IV 37% · EM ±7.6%Jun 24 — IV 37% · EM ±7.5%Jun 25 — IV 37% · EM ±7.2%Jun 26 — IV 37% · EM ±7.0%Jun 29 — IV 37% · EM ±6.5%Jun 30 — IV 38% · EM ±6.6%Jul 01 — IV 38% · EM ±6.3%Jul 02 — IV 37% · EM ±6.0%Jul 03 — IV 38% · EM ±6.0%Jul 06 — IV 34% · EM ±4.7%Jul 07 — IV 40% · EM ±5.3%Jul 08 — IV 41% · EM ±5.1%Jul 09 — IV 41% · EM ±4.8%Jul 10 — IV 36% · EM ±3.9%Jul 13 — IV 45% · EM ±3.7%Jul 14 — IV 45% · EM ±3.3%Jul 15 — IV 81% · EM ±4.8%Jul 16 — IV 118% · EM ±4.9%Jul 20 — IV 39% · EM ±9.3%Jul 21 — IV 39% · EM ±9.2%Jul 22 — IV 39% · EM ±8.9%Jul 23 — IV 40% · EM ±8.9%Jul 24 — IV 39% · EM ±8.7%Jul 27 — IV 41% · EM ±8.6%Jul 28 — IV 40% · EM ±8.2%Jul 29 — IV 40% · EM ±8.1%Jul 30 — IV 41% · EM ±8.0%Jul 31 — IV 41% · EM ±7.8%Aug 03 — IV 42% · EM ±7.5%Aug 04 — IV 45% · EM ±7.7%Aug 05 — IV 44% · EM ±7.4%Aug 06 — IV 42% · EM ±6.7%Aug 07 — IV 42% · EM ±6.6%Aug 10 — IV 43% · EM ±5.9%Aug 11 — IV 43% · EM ±5.7%Aug 12 — IV 42% · EM ±5.3%Aug 13 — IV 42% · EM ±5.0%Aug 14 — IV 45% · EM ±5.0%Aug 17 — IV 52% · EM ±4.3%Aug 18 — IV 46% · EM ±3.4%Aug 19 — IV 72% · EM ±4.2%Aug 20 — IV 77% · EM ±3.2%Aug 24 — IV 32% · EM ±6.8%Aug 25 — IV 34% · EM ±6.9%Aug 26 — IV 32% · EM ±6.5%Aug 27 — IV 32% · EM ±6.3%Aug 28 — IV 32% · EM ±6.2%Aug 31 — IV 33% · EM ±5.8%Sep 01 — IV 33% · EM ±5.6%Sep 02 — IV 32% · EM ±5.4%Sep 03 — IV 31% · EM ±5.1%Sep 04 — IV 31% · EM ±4.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in